This is at way to early a stage to plan around. It is just reaching human safety trials, which is the very earliest part of human trials looking solely for adve

This is at way to early a stage to plan around. It is just reaching human safety trials, which is the very earliest part of human trials looking solely for adverse effects. Even in the best possible scenario it would be many years still before this might be available as a treatment. Most drugs which reach this phase of development do not ever become available as a treatment.